(Last updated : 2024-05-27 15:03:07)
  Masao Nakata
   Department   Kawasaki Medical School  Kawasaki Medical School, Department of General Thoracic Surgery,
   Position   Professor
■ Present specialized field
Respiratory surgery 
■ BooK
1. 2004   Evaluation of ischmic limbs by measuring transcutaneous oxygen tension and skin perfusion pressure, Breakthrough in the Treatment for Critical Limb Ischemia in Japan 
■ Journal
1. 2023/11/10 A case of an atypical variant of type A thymoma presenting with a gradually enlarging tumor over a 10-year period 
3. 2023/05/19 Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)-IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201  Link
4. 2023/01/11 Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers 
5. 2022/09/17 Efects of tumor‑infltrating CD8+ T cells, PD1/PD‑L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra‑pleural pneumonectomy  Link
Display all(88)
■ Presentation
1. 2022/08/06 Serum NY-ESO-1 and XAGE1 antibodies predict and monitor clinical responses to immune checkpoint therapy for NSCLC (Poster notice,General) 
2. 2022/04/15 Conversion or salvage surgery for patients with unresectable stage III non-small-cell lung cancer (Speech,Panelist at Symposium/Workshop (Applied)) 
3. 2021/11/01 Analysis of long-term outcomes after surgical resection in patients with non-small-cell lung cancer (Speech,General) 
4. 2019/09/28 JAK-STAT inhibitor overcomes interferon g-reduced, NK cell-mediated cytotoxicity in non-small-cell lung cancer cells. (Poster notice,General) 
5. 2019/04/20 Clinical effectiveness of perioperative multi-disciplinary team management for lung cancer surgery (Speech,Panelist at Symposium/Workshop (Applied)) 
Display all(48)